Ege University
Izmir, 35100, Turkey (Türkiye)
NCT Number: NCT04776226
It is not clear whether depresssion can predispose, or precipitate stroke recurrence in patients with stroke. We sought the relationship of post stroke depression with stroke recurrence.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Izmir, 35100, Turkey (Türkiye)
A large body of evidence suggests that depression is associated with a increased risk of many chronic diseases, including hypertension, diabetes, stroke and particularly coronary heart disease. Post stroke depression (PSD) may develop as a result of vascular disease. A previous meta-analysis showed that depression significantly increased the risk of development of stroke, and this increase was probably independent of other risk factors, including hypertension and diabetes.
Clarifying this issue has important implications; if depression increases the risk of development of recurrent stroke, so treating PSD might decrease the occurrence of recurrent stroke. To our knowledge there is no study attempting to clarify the relationship between PSD treatment and stroke recurrence. To fill these gap, we systematically conducted a study to assess whether PSD is associated with recurrent stroke, cardiovascular events or death. Thus, in the current study, three different arms of follow-up of patients with first-ever stroke, were used to predict the outcome over 52 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Antidepressant use in patients with depression
Other names: Treatment group, Nontreatment group
Time frame: 12 months
Standard World Health Organization definitions were used for recurrent stroke
Time frame: 12 months
Cardiovascular events were defined and recorded over the study period if they had at least one of the following: myocardial infarction; unstable angina; angina; percutaneous coronary intervention; or coronary artery bypass graft surgery.
Ege University
Other
Impact of Pots-stroke Depression Treatment on Stroke Recurrence
Acronym: STROKE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07174414
Brain Diseases, Brain Ischemia
Stanford, California, United States
View Trial DetailsNCT01027273
Brain Diseases, Brain Ischemia
New York, United States
View Trial DetailsNCT07611136
Biomarkers, Brain Diseases
Ulm, Baden-Wurttemberg, Germany
View Trial DetailsNCT07500116
Brain Diseases, Brain Ischemia
Barcelona, Spain
View Trial Details